Dare Bioscience, Inc. Total Assets

Quick Answer

Dare Bioscience, Inc. reported Total Assets of $32.47 million for the year ending 2025.

  • Dare Bioscience, Inc. showed an increase of +46.9% in Total Assets from 2024 to 2025.
  • This data is from Dare Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: $11.85 million | Q2 2014: $65.74 million | Q3 2014: $60.09 million | Q1 2015: $59.38 million | Q2 2015: $88.10 million | Q3 2015: $80.12 million | Q1 2016: $63.02 million | Q2 2016: $49.89 million | Q3 2016: $40.13 million | Q1 2017: $15.95 million | Q2 2017: $8.15 million | Q3 2017: $23.27 million | Q1 2018: $16.63 million | Q2 2018: $13.48 million | Q3 2018: $10.80 million | Q1 2019: $5.02 million | Q2 2019: $7.26 million | Q3 2019: $3.88 million | Q1 2020: $10.21 million | Q2 2020: $8.57 million | Q3 2020: $7.66 million | Q1 2021: $10.52 million | Q2 2021: $14.82 million | Q3 2021: $48.81 million | Q1 2022: $49.19 million | Q2 2022: $51.39 million | Q3 2022: $50.38 million | Q1 2023: $30.37 million | Q2 2023: $23.21 million | Q3 2023: $25.05 million | Q1 2024: $13.01 million | Q2 2024: $23.61 million | Q3 2024: $18.06 million | Q1 2025: $18.62 million | Q2 2025: $12.98 million | Q3 2025: $30.75 million.
  • Over the full 13 years of available data (2013 to 2025), Dare Bioscience, Inc.'s Total Assets has grown by 375.7%.
  • Historical annual values: Fiscal year 2025: $32.47 million | Fiscal year 2024: $22.10 million | Fiscal year 2023: $21.28 million | Fiscal year 2022: $43.83 million | Fiscal year 2021: $55.81 million | Fiscal year 2020: $7.55 million | Fiscal year 2019: $7.44 million | Fiscal year 2018: $7.83 million | Fiscal year 2017: $14.26 million | Fiscal year 2016: $44.6 thousand | Fiscal year 2015: $78.23 million | Fiscal year 2014: $53.39 million | Fiscal year 2013: $6.83 million.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: